Women's health drug maker reports loss of $0.12 per share.

2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories (COB) announced financial results for the second quarter and 6 months ended June 30, 2003.

For the second quarter of 2003, the company reported a loss of $4,366,608, or $0.12 per share, on sales of $4,919,800, as compared to a net loss of $4,855,498, or $0.14 per share, on sales of $2,455,149 in the second quarter of 2002.

Second quarter 2003 net revenues reflected a 36% increase in sales over first quarter 2003, as a result of increased sales of Prochieve 8% (progesterone gel), Prochieve 4% (progesterone gel), RepHresh Vaginal Gel and Advantage-S Bioadhesive Contraceptive Gel in direct response …